Anticoagulant Falls Short for Secondary Stroke Prevention in Atrial Cardiopathy

(MedPage Today) -- Oral anticoagulation (OAC) was no better than low-dose aspirin for secondary stroke prevention in people with left atrial cardiopathy absent evidence of atrial fibrillation (Afib or AF), the ARCADIA trial showed. Recurrent strokes...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news